SNT 6.25% 4.3¢ syntara limited

cystic fibrosis trial reaches target recruitment, page-3

  1. 1,300 Posts.
    lightbulb Created with Sketch. 69
    Sweet. Next possible announcements after successful results could be FDA Orphan status and a Fastrack to market completely bypassing Phase 3.

    Bring it on.
 
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.